pepmg_

Study summary · research use only

Rubidium-82 generator yield and efficiency for PET perfusion imaging: Comparison of two clinical systems

Observational · human · Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2020 · DOI 10.1007/s12350-020-02200-6 · PMID 32436115

Plain-language summary

Paraphrased from the published abstract below — not a verdict on whether anything works.

This technical comparison study (species not specified; PET imaging systems evaluated) compared 82Rb isotope yield and production efficiency between two FDA-approved generators, CardioGen-82 and RUBY-FILL, using 515 daily quality assurance reports from 9 CardioGen-82 and 9 RUBY-FILL generators over 2 years, with a correction factor derived from RUBY-FILL test elutions to place values on a common scale. The authors report that reported 82Rb activity was lower for CardioGen-82 than RUBY-FILL (2.3 ± 0.2 vs 3.0 ± 0.2 GBq, P<0.001), that CardioGen-82 values underestimated RUBY-FILL activity by about 24%, and that after conversion, CardioGen-82 efficiency remained lower than RUBY-FILL (88 ± 4% vs 95 ± 4%, P<0.001), with CardioGen-82 yield about 7% lower overall.

Abstract

Strontium-82/Rubidium-82 (82Sr/82Rb) generators are used widely for positron emission tomography (PET) imaging of myocardial perfusion. In this study, the 82Rb isotope yield and production efficiency of two FDA-approved 82Sr/82Rb generators were compared. N = 515 sequential daily quality assurance (QA) reports from 9 CardioGen-82® and 9 RUBY-FILL® generators were reviewed over a period of 2 years. A series of test elutions was performed at different flow-rates on the RUBY-FILL® system to determine an empirical correction-factor used to convert CardioGen-82® daily QA values of 82Rb activity (dose-calibrator 'maximum' of 50 mL elution at 50 mL·min-1) to RUBY-FILL® equivalent values (integrated 'total' of 35 mL elution at 20 mL·min-1). The generator yield (82Rb) and production efficiency (82Rb yield/82Sr parent activity) were measured and compared after this conversion to a common scale. At the start of clinical use, the system reported 82Rb activity from daily QA was lower for CardioGen-82® vs RUBY-FILL® (2.3 ± 0.2 vs 3.0 ± 0.2 GBq, P < 0.001) despite having similar 82Sr activity. Dose-calibrator 'maximum' (CardioGen-82®) values were found to under-estimate the integrated 'total' (RUBY-FILL®) activity by ~ 24% at 50 mL·min-1. When these data were used to convert the CardioGen-82 values to a common measurement scale (integrated total activity) the CardioGen-82® efficiency remained slightly lower than the RUBY-FILL® system on average (88 ± 4% vs 95 ± 4%, P < 0.001). The efficiency of 82Rb production improved for both systems over the respective periods of clinical use. 82Rb generator yield was significantly under-estimated using the CardioGen-82® vs RUBY-FILL® daily QA procedure. When generator yield was expressed as the integrated total activity for both systems, the estimated 82Rb production efficiency of the CardioGen-82® system was ~ 7% lower than RUBY-FILL® over the full period of clinical use.

Read the full study on PubMed ↗ Open-access full text ↗

pepmg summarizes the peer-reviewed literature and links to every source — it sells nothing, ships nothing, and gives no medical, dosing, or human-use guidance. Don't just trust this summary: follow the citation to its source and read it yourself. Research use only.